Suscribirse

Epidemiology and mortality in older patients treated by reverse shoulder arthroplasty for displaced proximal humerus fractures - 05/12/19

Doi : 10.1016/j.otsr.2019.07.026 
Emmanuel Maugendre a, Benjamin Gadisseux a, Christophe Chantelot a, Philippe Clavert b, Nassima Ramdane c, Jean-David Werthel d, Pascal Boileau e,

SOFCOTf

a Service de traumatologie, CHRU de Lille, hôpital Roger Salengro, 2, avenue Oscar-Lambret, 59037 Lille, France 
b Service d’orthopédie-traumatologie, centre de chirurgie orthopédique et de la main, service de chirurgie orthopédique, avenue Baumann, 67400 Illkirch, France 
c EA 2694 — santé publique: épidémiologie et qualité des soins, université de Lille, CHU de Lille, 59000 Lille, France 
d Hôpital Ambroise-Paré Paris, 9, avenue Charles-de-Gaulle, 92104 Boulogne-Billancourt, France 
e iULS — Institut universitaire locomoteur and sport, CHU de Nice, hôpital Pasteur 2, 30, voie Romaine, 06000 Nice, France 
f Société française de chirurgie orthopédique et traumatologique, 56, rue Boissonade, 75014 Paris, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Introduction

Reverse shoulder arthroplasty (RSA) is rapidly becoming the preferred treatment for displaced proximal humerus fractures in older patients. However, few studies have analyzed the target population and the effect of RSA on survival, although the socioeconomic impact of this type of surgery is considerable.

Patients and methods

This was a retrospective epidemiological study of all patients with a displaced proximal humeral fracture treated by RSA in 14 public and private hospitals throughout France between 1995 and 2016. The French hospital discharge database (PMSI) was analyzed to isolate an 898-patient cohort who underwent RSA within 6 weeks of the fracture event. In 87% of cases, this was a 3- or 4-fragment fracture. We analyzed the epidemiological characteristics of the patients at the time of fracture, their survival (Kaplan-Meier estimate) and factors that may impact survival.

Results

The mean age at the time of fracture and surgery was 79 years (46–98 years). Eighty percent of the cohort was female (sex ratio: 0.18 [p=0.0042], with 21% obesity rate [BMI>30]) and 60% of patients were ASA 1–2. The most common comorbidities were cardiovascular and neurological. The survival rate after RSA was 94% at 1 year and 73% at 5years. At the latest follow-up of 19 years, 42% of patients were still alive. In 18% of cases, the patient died within the first 15 days. The presence of comorbidities (ASA score>3–4) (p<0.004) and/or cognitive disorders (p<0.0001) were risk factors for early mortality. The time to surgery, type of fracture, associated fractures and discharge destination (return home, transfer to nursing home) had no effect on postoperative mortality in our cohort.

Conclusion

Despite being older (79 years) at the time of proximal humerus fracture, patients who underwent RSA treatment had a high survival rate (94% at 1 year, 73% at 5years), which is better than the survivorship reported after surgical treatment of femoral neck fractures (81–87% at 1 year, 38% at 5years). The presence of comorbidities (ASA>3–4) and/or cognitive disorders are risk factors for early mortality and should be taken into account to prevent early death.

Level of evidence

IV, Retrospective study.

El texto completo de este artículo está disponible en PDF.

Keywords : Fracture, Proximal humerus, Mortality, Age, Implant, Arthroplasty


Esquema


 Word issued from the 2016 SOFCOT symposium “Outcomes of reverse shoulder arthroplasty in acute proximal humerus fractures”.


© 2019  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 105 - N° 8

P. 1509-1513 - décembre 2019 Regresar al número
Artículo precedente Artículo precedente
  • Variation of the glenohumeral and scapulothoracic motion in progressive severity of glenohumeral osteoarthritis
  • David M. Spranz, Hendrik Bruttel, Jan M. Eckerle, Sebastian I. Wolf, Gregor Berrsche, Michael W. Maier
| Artículo siguiente Artículo siguiente
  • Factors associated with internal rotation outcomes after reverse shoulder arthroplasty
  • Morgane Rol, Luc Favard, Julien Berhouet, la Société d’orthopédie de l’Ouest (SOO)

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.